Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Linsitinib | 0.1 | uM | 9 | 5000.00 | 2808.68 | 7506.00 | 7795.00 | 0.9629 | 0.9493 |
| BT-20 | Lapatinib | 3.1623 | uM | 9 | 5000.00 | 2808.68 | 5826.00 | 7795.00 | 0.7474 | 0.6412 |
| BT-20 | Linsitinib | 10 | uM | 9 | 5000.00 | 2808.68 | 6137.00 | 7795.00 | 0.7873 | 0.7002 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 5000.00 | 2808.68 | 7616.00 | 7795.00 | 0.9770 | 0.9687 |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 5000.00 | 2808.68 | 4646.00 | 7795.00 | 0.5960 | 0.4074 |
| BT-20 | Erlotinib | 1 | uM | 9 | 5000.00 | 2808.68 | 6474.00 | 7795.00 | 0.8305 | 0.7631 |
| BT-20 | 17-AAG | 0.0031623 | uM | 9 | 5000.00 | 2808.68 | 7852.00 | 7795.00 | 1.0073 | 1.0099 |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 8022.00 | 7795.00 | 1.0291 | 1.0394 | |
| BT-20 | Linsitinib | 1 | uM | 9 | 5000.00 | 2808.68 | 7595.00 | 7795.00 | 0.9743 | 0.9650 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 5000.00 | 2808.68 | 7761.00 | 7795.00 | 0.9956 | 0.9941 |
| BT-20 | Lapatinib | 0.31623 | uM | 9 | 5000.00 | 2808.68 | 7969.00 | 7795.00 | 1.0223 | 1.0302 |
| BT-20 | 17-AAG | 0.0001 | uM | 9 | 5000.00 | 2808.68 | 7908.00 | 7795.00 | 1.0145 | 1.0196 |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 7880.00 | 7795.00 | 1.0109 | 1.0148 | |
| BT-20 | 17-AAG | 0.000302 | uM | 9 | 5000.00 | 2808.68 | 7793.00 | 7795.00 | 0.9997 | 0.9997 |
| BT-20 | Erlotinib | 10 | uM | 9 | 5000.00 | 2808.68 | 4949.00 | 7795.00 | 0.6349 | 0.4691 |
| BT-20 | 17-AAG | 0.001 | uM | 9 | 5000.00 | 2808.68 | 7884.00 | 7795.00 | 1.0114 | 1.0155 |
| BT-20 | Lapatinib | 10 | uM | 9 | 5000.00 | 2808.68 | 3760.00 | 7795.00 | 0.4824 | 0.2191 |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 7954.00 | 7795.00 | 1.0204 | 1.0276 | |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 7851.00 | 7795.00 | 1.0072 | 1.0097 | |
| BT-20 | 17-AAG | 0.000066069 | uM | 9 | 5000.00 | 2808.68 | 7907.00 | 7795.00 | 1.0144 | 1.0195 |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 7659.00 | 7795.00 | 0.9826 | 0.9762 | |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 7602.00 | 7795.00 | 0.9752 | 0.9662 | |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 5000.00 | 2808.68 | 7415.00 | 7795.00 | 0.9513 | 0.9333 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 5000.00 | 2808.68 | 6057.00 | 7795.00 | 0.7770 | 0.6851 |
| BT-20 | 17-AAG | 0.31623 | uM | 9 | 5000.00 | 2808.68 | 2331.00 | 7795.00 | 0.2990 | -0.1189 |